Navigation Links
Efficacy of stents is improved when their placement is determined by arterial blood flow measurement
Date:2/6/2009

Reperfusion therapy in the form of percutaneous coronary intervention (PCI) is now the recommended first treatment for victims of acute myocardial infarction. New European guidelines issued in November 2008 emphasised speed of action and the importance of reperfusion therapy to restore blood flow to the heart and improve survival rates. The benefits of PCI are less clear in patients with stable coronary artery disease; PCI has been shown to improve symptoms, but the impact on prognosis is still a matter of debate.

The cornerstone of PCI is the technique of angioplasty, by which either bare-metal or drug-releasing stents are located within the coronary arteries at points of occlusion. The FAME study, reported in the 15 January issue of the New England Journal of Medicine, was a randomised trial designed to assess the most effective method of locating the stent in patients with multivessel disease: conventional angiography (visualisation of the artery) or a new technique of "fractional flow reserve" (FFR), by which a tiny wire with a sensor is threaded through the coronary artery to the point of occlusion and blood flow measured to determine if the lesion is restricting blood flow and causing ischemia.(1)

The study, conducted in 20 European and US centres, randomised more than 1000 patients with multivessel coronary disease to either of the two methods for placement of stents. Results showed that one-third fewer stents were used in the FFR group and the difference in composite outcome at one year was significant: the FFR group showed a 28% lower incidence of major adverse cardiac events (repeat angioplasty, heart attack or death) - 18.3% vs. 13.2%.

The implication in these results is that placing stents in lesions not responsible for ischemia is not only unnecessary, but may cause worse outcomes.

Commenting on the study on behalf of the European Society of Cardiology, Professor Uwe Zeymer from the Herzzentrum, Ludwigsh
'/>"/>

Contact: ESC Press Office
press@escardio.org
33-049-294-8627
European Society of Cardiology
Source:Eurekalert

0

GOOD

Page: 1 2

Related medicine news :

1. Senesco Announces Results of Pre-Clinical Efficacy, Toxicology and Dose Ranging Studies for Multiple Myeloma Therapeutic Candidate
2. SCOLR Pharma, Inc. Announces Positive Top-Line Results From Pivotal Clinical Trial Evaluating Efficacy of Extended-Release Ibuprofen
3. New Analyses Confirm Nexavars Efficacy and Safety in Multiple Patient Subsets With Liver Cancer
4. WVU study demonstrates efficacy of CT perfusion in diagnosis of acute ischemic stroke
5. Topical treatment for cold sores achieves efficacy of oral drugs; represents paradigm shift
6. Enbrel(R) (etanercept) Is the First Biologic With Published Efficacy and Safety Data for up to a Decade of Continuous Use for the Treatment of Moderate to Severe Rheumatoid Arthritis
7. Accuracy, efficacy and ethics of abstinence-only programs questioned by public health experts
8. Head-to-Head 96-Week Study Shows EPZICOM(R) is Comparable to Truvada(R) in Efficacy and Safety Measures in HIV Treatment-Naive Patients
9. Overcoming inhibitors of cell death improves cancer therapy efficacy
10. New Long-Term HUMIRA(R) (adalimumab) Data Show Up to Seven-Year Efficacy with Combination Treatment for Rheumatoid Arthritis
11. A Drug With Efficacy Superior to That of Remicade at Inducing Closure and Healing of Fistulas Would Earn a 30 Percent Patient Share in the Crohns Disease Drug Market

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)...Newswire/ -- The following is an op-ed by Jeffrey ...ies: ,, Credit Senators John Kerry (D-MA) and R... to the health care debate: a bill ends a glaring ...etonuria (PKU) control their potentially devastati... chronic conditions are treated. "The Medical Foo...
(Date:12/4/2009)...nal of Neurosurgery: Pediatrics finds that operat...oma, or JPA, tumors in the thalamus of the brain c...DTI. The sensitivity of DTI imaging allows for th...n. This information can maximize the potential of...ge to the fiber bundles that are directly related ...
(Date:12/4/2009)...rsonality, study finds , , FRIDAY, Dec. ...ne social network, such as Facebook, reveal the re...new study, which finds that people tend to express.... , "I was surprised by the findings because t... their profiles to promote an enhanced impression ...
(Date:12/4/2009)...ing manufacturer of over-the-counter topical cream...ers’ quality of life, today announced that i...Medical Association (APMA) Seal of Approval for it..., (PRWEB) December 4, 2009...he-counter topical cream and first aid products de...
(Date:12/4/2009)...company GemaTech launches its new approach to emer...t (PRU) is a call re-routing solution offered on a...ganisations to rapidly re-route their incoming cal...tion, with additional voice recording if desired, ...ion . , (PRWEB) December ...
Breaking Medicine News(10 mins):Health News:Health Leadership from Sen. Kerry and Sen. Casey: A Cure for Devastating Discrimination in Insurance Coverage for PKU Patients is on the Move 2Health News:Health Leadership from Sen. Kerry and Sen. Casey: A Cure for Devastating Discrimination in Insurance Coverage for PKU Patients is on the Move 3Health News:Online Identities Likely to Match Reality 2Health News:Tender Corp.'s HealthiFeet Awarded American Podiatric Medical Association Seal of Approval 2Health News:Tender Corp.'s HealthiFeet Awarded American Podiatric Medical Association Seal of Approval 3Health News:Tender Corp.'s HealthiFeet Awarded American Podiatric Medical Association Seal of Approval 4Health News:GemaTech Launches Portable Recovery Unit. The Latest Design in Emergency Telecoms Resilience and Continuity 2
...tarting Down syndrome infants on treadmill trainin...four or five months earlier than with only traditi...sity of Michigan says. , The study also suggests ... from locomotion: social skills, motor skills, adv...
...dyslexia struggle to read because their brains are..., according to a brain-imaging study published thi...euroscience (online October 16). The study found t...ding to the study,s first author, Nadine Gaab, PhD...
...alifornia will simultaneously open their doors We...ited to cover the,festivities, SAN FRANCISCO, Oct... a nursing home. Nurse administrators don,t often,...than 150 nursing homes in California this Hallowee...
...alifornia will simultaneously open their doors We...vited to cover the festivities, LOS ANGELES, Oct....a nursing home. Nurse administrators don,t often,s...han 150 nursing homes in California this Halloween...
...rn, a leading global clinical,research organizatio...al,Trial Management Services, Inc. (CTMS) a Bristo...ces throughout the United States. From February,20...ve experience conducting clinical trials in a wide...
...piest surprise this Halloween may actually be in t...turday at the American Heart Association conferenc...y mini-size Halloween candies when they kept the w...at the American Heart Association conference in Or...
Other Medicine News:Health News:Treadmill training helps Down syndrome babies walk months earlier 2Health News:Sound training rewires dyslexic children's brains for reading 2Health News:Sound training rewires dyslexic children's brains for reading 3Health News:Halloween Events in the Bay Area Bring Young and Old Together for a Ghoulish Good Time 2Health News:Halloween Events in Los Angeles Bring Young and Old Together for a Ghoulish Good Time 2Health News:Halloween Events in Los Angeles Bring Young and Old Together for a Ghoulish Good Time 3Health News:Chiltern Announces Acquisition of an Independent USA Based Clinical Research Organization, Clinical Trial Management Services, Inc. 2Health News:Food 'tricks' that combat sneaky, creepy Halloween treats 2
(Date:12/3/2009)...ISON, N.J., Dec. 3 A gen...of developing a potentially life-threatening blood...rapies or chemicals is one of several medical disc...est Diagnostics (NYSE: DGX ) will present during...ual Meeting and Exposition, December 5-8, 2009, in...
(Date:12/3/2009)...ILMINGTON, Del., Dec. 3 ParagonRx,...utical risk management and optimal medication use,... the FDA,s draft guidance on REMS - Risk Evaluatio...ons for REMS lifecycle management. Dr. Gary Slatk...t on REMS and risk management programs, will lead ...
(Date:12/3/2009)...N DIEGO, Dec. 3 Cardium ...at its wholly-owned subsidiary, Tissue Repair Comp...ing with the U.S. Food and Drug Administration (FD...TM) product candidate based on positive data from...clinical study. Today,s submission with the FDA c...
Breaking Medicine Technology:Quest Diagnostics Reveals New Genetic Discoveries for Testing for Leukemia, Lymphoma and Blood Clotting at 51st ASH Meeting and Exposition 2Quest Diagnostics Reveals New Genetic Discoveries for Testing for Leukemia, Lymphoma and Blood Clotting at 51st ASH Meeting and Exposition 3Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds 2Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds 3Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds 4Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds 5First 5 California Approves 2481 4 Million Contribution to Help Restore Healthy Families Programs Viability 54507 1First 5 California Approves 2481 4 Million Contribution to Help Restore Healthy Families Programs Viability 54507 2Some Birth Control Pills Safer Than Others 54505 1Some Birth Control Pills Safer Than Others 54505 2Some Birth Control Pills Safer Than Others 54505 3Chiropractors Focus on Patients Best Interest 54503 1
...ersome" vaginal atrophy, symptoms among sexually...women; results presented today at 19th Annual Nort...ciety Meeting, ANN ARBOR, Mich., Sept. 24 Additi...pemifene tablets) for the treatment of,symptoms of...n showed that,Ophena(TM) significantly improves a ...
...to Raise Awareness about,the Importance of Clinica...News facts:, -- Most Americans with cancer woul...rials if they knew about them. -- In a surve... unaware or unsure that participation in ...ive percent said they would have been willing to e...
Other Medicine Technology:QuatRx Pharmaceuticals Announces Additional Data From Phase 3 Study for Ophena(TM) (Ospemifene Tablets) Showing Improvements in Clinical Symptoms of Vulvovaginal Atrophy 2QuatRx Pharmaceuticals Announces Additional Data From Phase 3 Study for Ophena(TM) (Ospemifene Tablets) Showing Improvements in Clinical Symptoms of Vulvovaginal Atrophy 3QuatRx Pharmaceuticals Announces Additional Data From Phase 3 Study for Ophena(TM) (Ospemifene Tablets) Showing Improvements in Clinical Symptoms of Vulvovaginal Atrophy 4Video: The Looming Crisis in Cancer Drug Development: 97% of Adult Cancer Patients Do Not Take Advantage of Clinical Trial Programs 2Video: The Looming Crisis in Cancer Drug Development: 97% of Adult Cancer Patients Do Not Take Advantage of Clinical Trial Programs 3
...VA for CELL-DYN are assayed linearity control kits... patient reportable range of three- and five-part ...linear performance of the analyzer. CVA and CVA fo... for each instrument model and provide instrument-...
LATITUDE® Patient Management System
...tary EX.P.R.T. Release Technology essentially elim... stent shortening,, Unique anatomically des...bifurcation,, 0.014 Rapid Exchange catheter...matic tip,, Radiopaque marker on catheter c...
...s a whole blood hematology control manufactured sp...d the Coulter AcT5diff instruments. The compositio...rential, positioning the populations within the li...oduct offers 105-day closed-vial stability and 14-...
Medicine Products: